Truist pointed to updated GLP-1 intake features, including Klarna financing, shorter shipping intervals and new semaglutide ...

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

Although Hims & Hers Health has tanked in the past month, the quantitative profile suggests a contrarian trade is brewing for ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of Labs, a new ...

The telehealth platform expects the new offering to add to its user base as it draws customers looking to prevent future ...

Global populations are aging, a reality that is leading to increased demand for healthcare services, chronic disease ...

When leadership divests their holdings on such a scale, especially during a period of operational strength, it sends a powerful message: a lack of confidence in the current valuation. Despite ...

After a tumultuous year, a popular virtual care platform is trying its hand in a competitive blood testing market.

Discover why Hims & Hers Health (HIMS) remains a strong long-term buy after robust Q3 growth, new offerings, and expansion ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

This week, the parents of Luke Tyler, the Washington State University (WSU) freshman who was found dead in his dorm room on January 22, 2023, filed a wrongful death lawsuit in the King County Superior ...

The parents of Luke Tyler, a WSU freshman found dead in his dorm, allege his death was a consequence of Hims' reckless ...